Seizure News and Research RSS Feed - Seizure News and Research

An epileptic seizure, occasionally referred to as a fit, is defined as a transient symptom of "abnormal excessive or synchronous neuronal activity in the brain".
New hope for patients with tuberous sclerosis complex

New hope for patients with tuberous sclerosis complex

Although it is rare, tuberous sclerosis complex (TSC) can be a difficult and frightening diagnosis for parents and children. The genetic disorder causes nonmalignant tumors to form in many different organs, including the brain, eyes, kidneys and heart. [More]
UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

UCB, a global biopharmaceutical leader, and Dermira, Inc., a privately held US-based dermatology company, announced today that they have entered into an exclusive licensing agreement for the development and future commercialization of Cimzia (certolizumab pegol) in dermatology. [More]
State highlights: N.C. lawmakers face off over Medicaid spending; heart surgery ratings in Ore.

State highlights: N.C. lawmakers face off over Medicaid spending; heart surgery ratings in Ore.

North Carolina senators were not persuaded Thursday to accept Medicaid spending numbers for the coming year from Gov. Pat McCrory's administration after hearing a two-hour presentation led by State Budget Director Art Pope. Pope was summoned by the Senate Appropriations Committee to explain why McCrory's spending projection earmarks are much less than the Senate's to pay for unpaid claims from the year ending June 30 and additional enrollment and services for next year. [More]
Vertex receives positive opinion from European CHMP for approval of KALYDECO for cystic fibrosis

Vertex receives positive opinion from European CHMP for approval of KALYDECO for cystic fibrosis

Vertex Pharmaceuticals Incorporated today announced that the European Committee for Medicinal Products for Human Use has issued a positive opinion recommending the approval of KALYDECO (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have one of eight non-G551D gating mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. [More]
Neurosurgeons implant new type of electrical stimulator to control seizures

Neurosurgeons implant new type of electrical stimulator to control seizures

On June 18, neurosurgeons at the University of Alabama at Birmingham implanted a new type of electrical stimulator to control seizures in patients with difficult-to-control epilepsy. [More]
International researchers discover genetic component of Idiopathic Generalized Epilepsy

International researchers discover genetic component of Idiopathic Generalized Epilepsy

An international team of researchers has discovered a significant genetic component of Idiopathic Generalized Epilepsy (IGE), the most common form of epilepsy. [More]

Health law bumps in the road: Subsidy eligibility questions, Medi-Cal asset seizure, health literacy

Obamacare programs designed to help people are running into problems concerning how much money people have when they get covered. [More]
2 medications equally effective in treating major epileptic brain seizures in children

2 medications equally effective in treating major epileptic brain seizures in children

A recently published clinical study in the Journal of the American Medical Association has answered an urgent question that long puzzled ER pediatricians: Is the drug lorazepam really safer and more effective than diazepam - the U.S. Food and Drug Administration-approved medication as first line therapy most often used by emergency room doctors to control major epileptic seizures in children? [More]
New study show direct link between depression and medication nonadherence

New study show direct link between depression and medication nonadherence

A new study led by Alan B. Ettinger, M.D., M.B.A., Director of the Epilepsy Center at Neurological Surgery, P.C., has found that many patients who fail to take their antiseizure medications are suffering from depression. [More]
Janssen, Viiv Healthcare to develop single tablet regimen for maintenance treatment of HIV

Janssen, Viiv Healthcare to develop single tablet regimen for maintenance treatment of HIV

Janssen R&D Ireland Ltd announced today that they have entered into a collaboration with ViiV Healthcare to develop and commercialize a new single tablet regimen containing Janssen's Non-Nucleoside Reverse Transcriptase Inhibitor rilpivirine (marketed as EDURANT®) and ViiV's Integrase Inhibitor dolutegravir(marketed as TIVICAY®) as the sole active ingredients for the maintenance treatment of people living with Human Immunodeficiency Virus (HIV). [More]
Combined MMRV vaccine slightly increases risk of febrile seizures in children

Combined MMRV vaccine slightly increases risk of febrile seizures in children

The combined measles-mumps-rubella-varicella (MMRV) vaccine shows a slightly increased risk of febrile seizures in children, compared with the previously separate vaccines for MMR and varicella (chickenpox) (MMR+V), according to an article in CMAJ (Canadian Medical Association Journal). [More]
SAGE reports preliminary data from SAGE-547 Phase 1/2 clinical trial for super-refractory status epilepticus

SAGE reports preliminary data from SAGE-547 Phase 1/2 clinical trial for super-refractory status epilepticus

SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat life-threatening, rare central nervous system (CNS) disorders, today announced preliminary data from its ongoing open-label Phase 1/2 clinical trial of SAGE-547, an allosteric modulator of GABAA receptors, in patients with super-refractory status epilepticus (SRSE). [More]
Penn and Mayo Clinic researchers launch Seizure Detection Challenge

Penn and Mayo Clinic researchers launch Seizure Detection Challenge

Researchers from Mayo Clinic and the University of Pennsylvania announce the launch of the Seizure Detection Challenge, an international competition inviting the best minds in "machine learning" to improve devices to track and treat epilepsy. [More]
MRI-guided SLAH procedure provides safe, effective alternative to surgery

MRI-guided SLAH procedure provides safe, effective alternative to surgery

For patients with mesial temporal lobe epilepsy (MTLE) that can't be controlled by medications, a minimally invasive laser procedure performed under MRI guidance provides a safe and effective alternative to surgery, suggests a study in the June issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. [More]
AbbVie releases preliminary results from ABT-414 Phase I study in patients with recurrent or unresectable GBM

AbbVie releases preliminary results from ABT-414 Phase I study in patients with recurrent or unresectable GBM

AbbVie released preliminary results from an ongoing Phase I study with ABT-414, an anti-epidermal growth factor receptor (EGFR) monoclonal antibody drug conjugate, in combination with temozolomide, which showed four objective responses, including one complete response, in patients with recurrent or unresectable glioblastoma multiforme. [More]

Transplantation of embryonic neural cells can alleviate epilepsy seizure activity in mice

New research from North Carolina State University pinpoints the areas of the cerebral cortex that are affected in mice with absence epilepsy and shows that transplanting embryonic neural cells into these areas can alleviate symptoms of the disease by reducing seizure activity. [More]
Study examines potential use of medical marijuana, CBD in treating epilepsy

Study examines potential use of medical marijuana, CBD in treating epilepsy

The therapeutic potential of medical marijuana and pure cannabidiol (CBD), an active substance in the cannabis plant, for neurologic conditions is highly debated. [More]
Can cannabis help curb convulsions?

Can cannabis help curb convulsions?

Experts say that vigorous investigations are needed to determine whether or not the medical use of marijuana would be of benefit to patients with epilepsy. [More]
NYU Langone Medical Center implants RNS device in brain for patients with epilepsy

NYU Langone Medical Center implants RNS device in brain for patients with epilepsy

NYU Langone Medical Center last month became the first hospital outside of a clinical trial site to implant a pacemaker-like device in the brain that may be a game-changer for patients with epilepsy. [More]
Eisai launches new class of epilepsy treatment Fycompa in France

Eisai launches new class of epilepsy treatment Fycompa in France

Fycompa (perampanel), the first in an entirely new class of treatment for partial onset seizures (the most common form of epilepsy), has today received reimbursement approval from the Comité Economique des Produits de Santé. [More]